[go: up one dir, main page]

MA38774A1 - Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders. - Google Patents

Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders.

Info

Publication number
MA38774A1
MA38774A1 MA38774A MA38774A MA38774A1 MA 38774 A1 MA38774 A1 MA 38774A1 MA 38774 A MA38774 A MA 38774A MA 38774 A MA38774 A MA 38774A MA 38774 A1 MA38774 A1 MA 38774A1
Authority
MA
Morocco
Prior art keywords
compounds
hyperproliferative
pyridinamines
inhibitors
substituted pyrazolo
Prior art date
Application number
MA38774A
Other languages
French (fr)
Inventor
Philip Lienau
Lars Wortmann
Ulrich Klar
Anja Richter
Franziska Siegel
Florian Puehler
Georg Kettschau
Keith Graham
Kirstin Petersen
Detlev Sülzle
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Priority claimed from PCT/EP2014/064347 external-priority patent/WO2015004024A1/en
Publication of MA38774A1 publication Critical patent/MA38774A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention porte sur des composés pyrazolopyridine substitués représentés par la formule générale (i), tels que décrits et définis dans la description, sur des procédés de préparation desdits composés, sur des composés intermédiaires utiles pour la préparation desdits composés, sur des associations et des compositions pharmaceutiques comprenant lesdits composés et sur l'utilisation desdits composés pour la fabrication d'une composition pharmaceutique pour le traitement ou la prophylaxie d'une maladie, en particulier d'un trouble hyperprolifératif et/ou relatif à l'angiogenèse, en tant qu'agent unique ou en association avec d'autres principes actifs.The present invention relates to substituted pyrazolopyridine compounds represented by the general formula (i), as described and defined in the description, to processes for the preparation of said compounds, to intermediate compounds useful for the preparation of said compounds, to combinations and pharmaceutical compositions comprising said compounds and the use of said compounds for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular a hyperproliferative and / or angiogenesis disorder, as a as a single agent or in combination with other active ingredients.

MA38774A 2013-07-08 2014-07-04 Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders. MA38774A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175526 2013-07-08
PCT/EP2014/064347 WO2015004024A1 (en) 2013-07-08 2014-07-04 Substituted pyrazolo-pyridinamines

Publications (1)

Publication Number Publication Date
MA38774A1 true MA38774A1 (en) 2018-05-31

Family

ID=48745840

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38774A MA38774A1 (en) 2013-07-08 2014-07-04 Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders.

Country Status (2)

Country Link
AR (1) AR096826A1 (en)
MA (1) MA38774A1 (en)

Also Published As

Publication number Publication date
AR096826A1 (en) 2016-02-03

Similar Documents

Publication Publication Date Title
MA40523A (en) 2- (MORPHOLIN-4-YL) -1,7-NAPHTHYRIDINES
MA35422B1 (en) Amine-substituted imidazopyridazines
MA41135B1 (en) Substituted benzamides 1,3-thiazol-2-yl
MA59379B1 (en) SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
MA35826B1 (en) Substituted triazolopyridines and their use as ttk inhibitors
MA33768B1 (en) Trichlorethylene
MA45020A (en) AROMATIC SULPHONAMIDE DERIVATIVES
MA47447A (en) 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR CANCER TREATMENT
MA41562B1 (en) 4-hydroxy-3- (heteroaryl) pyridine-2-one agonists for use in the treatment of cardiovascular disorders
MA34308B1 (en) SUBSTITUTED TRIAZOLOPYRIDINES
MA35601B1 (en) Hydroxymethyl substituted pyrrolotriazines used as alk1 inhibitors
MA40111B1 (en) Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein
MA44474B1 (en) FERROPORTIN INHIBITORS
MA35342B1 (en) Piperidinyl compounds useful as inhibitors of tankyrase
MA40768A (en) MONO OR DI-SUBSTITUTE INDOLE DERIVATIVES AS DENGUE VIRUS REPLICATION INHIBITORS
MA29411B1 (en) 1H-QUINAZOLINE -2,4-DIONES AND THEIR USE AS AMPA RECEPTOR LIGANDS
MA40955B1 (en) 2-amino-6- (difluoromethyl) -5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
MA38358A1 (en) Formulations of organic compounds
MA47082B1 (en) Aromatic carboxylic acid amides as bradykinin b1 receptor antagonists
MA43913A (en) POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M1 RECEPTOR
MA41174B1 (en) Imidazopyridazine derivatives used as pi3kbeta inhibitors
MA42769B1 (en) Fluoroindole derivatives as positive allosteric modulators of the m1 muscarinic receptor
MA39229A1 (en) Pyrrolidines, terrahydrofurans and substituted cyclopentanes useful as orexin receptor antagonists
MA39750B1 (en) Derivatives of aza-indol-acetic acid and their use as modulators of prostaglandin receptors d2
MA38774A1 (en) Substituted pyrazolo-pyridinamines inhibitors of mknk1 kinase for use in hyperproliferative and / or angiogenesis disorders.